Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03209440 · ClinicalTrials.gov registry record · NA
Palliative Care for Elderly Outpatients
A NA study of Cancer Terminal, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 579
- Enrollment target
- 1
- Study location
NCT03209440: Completed NA study of Cancer Terminal, sponsored by University of Florida.
NCT03209440 is a NA study of Cancer Terminal that has completed, run by University of Florida. The registered enrollment target is 579 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03209440, a NA study of Cancer Terminal, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 579 participants
- Enrollment target
- 1
- Study location
Study Summary
Our long-term goal is to improve spiritual care outcomes for elderly patients with cancer. The study team will use a spiritual intervention, Dignity Therapy (DT), to help these patients maintain pride, find spiritual comfort, enhance continuity of self, and ultimately make meaning of their life threatening illness.
Primary Outcome
Our primary outcome measure is a 7-item Dignity Impact Scale. The items are scored on a 5-point scale from 'strongly disagree' (1) to 'strongly agree' (5). The scores can range from 7 to 35 with higher scores representing better outcome.
Conditions Studied
Interventions
- BEHAVIORAL Usual care
- BEHAVIORAL Dignity Therapy - Nurse Led
- BEHAVIORAL Dignity Therapy - Chaplain Led
Study Locations (1)
Florida
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 579 participants |
| Start Date | 2017-07-26 |
| Est. Completion | 2022-08-31 |
| Phase | NA |
What the finished NCT03209440 record still lists
NCT03209440 is an interventional study that assigns participants to a tested intervention. The registered 579 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (59% lower).
The record links to 1 condition, with Cancer Terminal appearing as the primary indexed condition, and to 3 interventions - of which Usual care is the first listed.
NCT03209440 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03209440 about?
NCT03209440 is a clinical study titled "Palliative Care for Elderly Outpatients". Our long-term goal is to improve spiritual care outcomes for elderly patients with cancer. The study team will use a spiritual intervention, Dignity Therapy (DT), to help these patients maintain pride, find spiritual comfort, enhance continuity of self, and ultimately make meaning of their life thre...
What is the current status of trial NCT03209440?
This trial is currently completed. It is a NA study. The enrollment target is 579 participants. The study started on 2017-07-26. Estimated completion is 2022-08-31.
What conditions does trial NCT03209440 study?
This clinical trial studies the following conditions: Cancer Terminal.
What interventions are being tested in trial NCT03209440?
The interventions under investigation include: Usual care (BEHAVIORAL), Dignity Therapy - Nurse Led (BEHAVIORAL), Dignity Therapy - Chaplain Led (BEHAVIORAL).
Who is sponsoring clinical trial NCT03209440?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03209440 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer Terminal
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03209440's enrollment target sits among peer trials
579 177th of 2000 higher than 1,824 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04575935 · 580 participants · Phase 3
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
- NCT05143177 · 580 participants · Phase 2
A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS)
- NCT05696353 · 580 participants · Phase 3
Teen Driving Translation Study (NIH)
- NCT06578104 · 580 participants
PULSED AF Post-Approval Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI